Joseph Kar-Taik Lim MD
Professor of Medicine, Section of Digestive Diseases/Yale Liver Center, Yale University School of Medicine
Join to View Full Profile
40 Temple Street, Suite 1ATemple Medical CenterNew Haven, CT 06510
Dr. Lim is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Gastroenterology, 2002 - 2005
Yale-New Haven Medical CenterResidency, Internal Medicine, 1999 - 2002
Northwestern University The Feinberg School of MedicineClass of 1999
Certifications & Licensure
CA State Medical License 2002 - Present
CT State Medical License 2005 - 2027
American Board of Internal Medicine Gastroenterology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Fellow (FACG) American College of Gastroenterology
Clinical Trials
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C Start of enrollment: 2007 Jul 01
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients Start of enrollment: 2008 Mar 01
- A Double-blind Study to Determine if Intraduodenal Indomethacin Can Decrease the Incidence of Post-ERCP Pancreatitis Start of enrollment: 2005 Aug 01
Publications & Presentations
PubMed
- 3 citationsTechnical systematic review supporting the 2025 AASLD Practice Guideline on management of chronic hepatitis B.Calvin Q Pan, Samer Saadi, Marc G Ghany, Jordan J Feld, Joseph K Lim
Hepatology. 2026-04-01 - 23 citationsAASLD ISDA Practice Guideline on treatment of chronic hepatitis B.Marc G Ghany, Calvin Q Pan, Anna S Lok, Jordan J Feld, Joseph K Lim
Hepatology. 2026-04-01 - Semaglutide versus resmetirom for noncirrhotic MASH with moderate to advanced fibrosis: a cost-effectiveness analysis.Basile Njei, Yazan A Al-Ajlouni, Dam Nsoh Tanih, Ulrick Sidney Kanmounye, Sarpong Boateng
Cost Effectiveness and Resource Allocation. 2026-03-20
Journal Articles
- A Comprehensive Assessment of Patient Reported Symptom Burden, Medical Comorbidities, and Functional Well Being in Patients Initiating Direct Acting Antiviral Therapy ...Souvik Sarkar, Michael W. Fried, Richard K. Sterling, Paul W. Stewart, Nancy Reau, Joseph K. Lim, David R. Nelson, Marina Serper, PLoS One
- Risk of Acute Liver Injury After Statin Initiation by Human Immunodeficiency Virus and Chronic Hepatitis C Virus Infection StatusDavid Rimland, Sheldon T Brown, Jay R Kostman, Adeel A Butt, Matthew Bidwell Goetz, Roger Bedimo, Joseph K Lim, Cynthia L Gibert, Clinical Infectious Diseases
Press Mentions
Listen to "Liver Cancer Screening: A New Tool for Improved-DetectionNovember 8th, 2024
ACG Guideline on Evaluation of Abnormal Liver Chemistries Recommends "New Normal" for Serum ALT LevelsFebruary 1st, 2017
Researchers Unveil Optimal Timing of HCV Therapy in TransplantationJanuary 24th, 2017
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
